2009
DOI: 10.1016/j.athoracsur.2009.05.056
|View full text |Cite
|
Sign up to set email alerts
|

The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2—Isolated Valve Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
690
5
19

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 1,115 publications
(722 citation statements)
references
References 9 publications
8
690
5
19
Order By: Relevance
“…So far, there are virtually no prospective randomized trials comparing minimally invasive valve surgery (MIMVS) and standard sternotomy (ST) in an unbiased way, and the majority of evidence rely on observational studies. Moreover, definition of the level of risk has been a controversial issue, mainly because the currently available tools of risk prediction in cardiac surgery such as EuroSCORE II [3] and The Society of Thoracic Surgery Predicted of Risk of Mortality [4] lose calibration and discrimination in the upper boundaries or deciles of surgical risk. Hence, defining where to draw the "red line" above which patients should be considered at high risk remains a challenge and an issue of debate.…”
Section: (Ann Thorac Surg 2015;-:---) ó 2015 By the Society Of Thoracmentioning
confidence: 99%
“…So far, there are virtually no prospective randomized trials comparing minimally invasive valve surgery (MIMVS) and standard sternotomy (ST) in an unbiased way, and the majority of evidence rely on observational studies. Moreover, definition of the level of risk has been a controversial issue, mainly because the currently available tools of risk prediction in cardiac surgery such as EuroSCORE II [3] and The Society of Thoracic Surgery Predicted of Risk of Mortality [4] lose calibration and discrimination in the upper boundaries or deciles of surgical risk. Hence, defining where to draw the "red line" above which patients should be considered at high risk remains a challenge and an issue of debate.…”
Section: (Ann Thorac Surg 2015;-:---) ó 2015 By the Society Of Thoracmentioning
confidence: 99%
“…Although surgical replacement with either a bioprosthetic or mechanical valve has been shown to confer a reduction in mortality in patients who survive the perioperative period, perioperative mortality with cardiac surgery in patients with ESRD remains extremely high and limits the surgical options in this patient population 105, 106, 107, 108. According to the Society of Thoracic Surgeons risk model, aortic valve replacement (AVR) in patients with ESRD is associated with significantly high perioperative mortality, with an odds ratio of 2.8 for operative mortality defined as death within the same hospitalization as surgery and within 30 days after discharge 109. Similarly, mitral valve repair is associated with an odds ratio of 4.59 for operative mortality 109.…”
Section: Valvular Disease In Patients With Esrdmentioning
confidence: 99%
“…Traditionally, surgical aortic valve replacement (SAVR) has been the mainstay of treatment for severe AS, but has been associated with 3.2% to 5.6% perioperative mortality when performed without and with concomitant coronary artery bypass graft surgery (CABG), respectively 3, 4. In high‐risk elderly patients, the risk of mortality approaches 10%, and 1 of 3 of these patients’ experiences a major morbidity 3, 4. A contributing factor to the adverse outcomes observed is that many of the elderly patients considered for SAVR are frail and have multiple chronic conditions 5…”
Section: Introductionmentioning
confidence: 99%